Literature DB >> 24533487

Review of angiogenesis in hepatocellular carcinoma.

Jun Muto1, Ken Shirabe, Keishi Sugimachi, Yoshihiko Maehara.   

Abstract

Hepatocellular carcinoma (HCC) is a hypervascular tumor, and its vascularity is unique and greatly different from peripheral parenchyma of liver. Afferent and efferent vessels of HCC lesions come to differ as the lesion develops. The characteristic of the flow regulates the common style of metastasis. The portal tract of the HCC lesion is the first site of the intrahepatic metastasis, because cancer cells roll into the portal vein via efferent flow. On microscopic observation, HCC displays marked vascular abnormalities, arteriogenesis and capillarization. Arteriogenesis is defined as the growth of functional collateral arteries covered with smooth muscle cells from pre-existing arteries. Sinusoidal capillarization involves the transformation of fenestrated hepatic sinusoids into continuous capillaries. Several angiogenic factors have been reported, and some of them are studied as prognostic factors or target molecules of chemotherapeutic reagents. However, the mechanism of neovascularization during HCC development is still unclear. This review discusses the characteristics of angiogenesis in HCC and known angiogenic factors of HCC.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  angiogenesis; arteriogenesis; hepatocellular carcinoma

Year:  2014        PMID: 24533487     DOI: 10.1111/hepr.12310

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  30 in total

1.  Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.

Authors:  Wei Wang; Guang-Yao Li; Jian-Yu Zhu; Da-Bing Huang; Hang-Cheng Zhou; Wen Zhong; Chu-Shu Ji
Journal:  Med Oncol       Date:  2015-03-22       Impact factor: 3.064

Review 2.  Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

Authors:  Giandomenico Roviello; Navid Sohbani; Roberto Petrioli; Maria Grazia Rodriquenz
Journal:  Invest New Drugs       Date:  2019-03-16       Impact factor: 3.850

3.  Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma.

Authors:  Markus Bo Schoenberg; Tong Zhu; Jingcheng Hao; Julian Nikolaus Bucher; Xiaokang Li; Xinyu Li; Yongsheng Han; Dionysios Koliogiannis; Michaela Svihla; Markus Otto Guba; Jens Werner; Alexandr V Bazhin
Journal:  Cancer Immunol Immunother       Date:  2021-09-28       Impact factor: 6.630

4.  AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.

Authors:  Yanmei Cui; Chuyong Lin; Zhiqiang Wu; Aibin Liu; Xin Zhang; Jinrong Zhu; Geyan Wu; Jueheng Wu; Mengfeng Li; Jun Li; Libing Song
Journal:  Oncotarget       Date:  2014-12-15

Review 5.  Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances.

Authors:  Renumathy Dhanasekaran; Salome Bandoh; Lewis R Roberts
Journal:  F1000Res       Date:  2016-05-12

6.  Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function.

Authors:  Jingnan Wang; Yunwen Shao; Bowei Liu; Xuezhu Wang; Barbara Katharina Geist; Xiang Li; Fang Li; Haitao Zhao; Marcus Hacker; Haiyan Ding; Hui Zhang; Li Huo
Journal:  BMC Med Imaging       Date:  2021-05-25       Impact factor: 1.930

7.  68Ga-Prostate-Specific Membrane Antigen Uptake as a Surrogate Biomarker of Neovascularity in Hepatocellular Carcinoma.

Authors:  Samreen Muzaffar; Najeeb Ahmed; Uzma Rahman; Fareeda Al Kandari; Sharjeel Usmani
Journal:  Indian J Nucl Med       Date:  2021-03-04

8.  A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.

Authors:  Yu Zou; Chuan-Gen Guo; Zheng-Gang Yang; Jun-Hui Sun; Min-Ming Zhang; Cai-Yun Fu
Journal:  Drug Des Devel Ther       Date:  2016-03-24       Impact factor: 4.162

9.  Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.

Authors:  Alexandra Barabasch; Nils A Kraemer; Alexander Ciritsis; Nienke L Hansen; Marco Lierfeld; Alexander Heinzel; Christian Trautwein; Ulf Neumann; Christiane K Kuhl
Journal:  Invest Radiol       Date:  2015-06       Impact factor: 6.016

10.  Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.

Authors:  Chi-Kuan Chen; Wen-Hsuan Yu; Tsu-Yao Cheng; Min-Wei Chen; Chia-Yi Su; Yi-Chieh Yang; Tsang-Chih Kuo; Ming-Tsan Lin; Ya-Chi Huang; Michael Hsiao; Kuo-Tai Hua; Mien-Chie Hung; Min-Liang Kuo
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.